Journal of the American Society of Hypertension
Volume 3, Issue 2 , Pages 105-112 , March 2009

Flavanols, the Kuna, cocoa consumption, and nitric oxide

  • Norman K. Hollenberg, MD, PhD

      Affiliations

    • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
    • Corresponding Author InformationCorresponding author: Norman K. Hollenberg, MD, PhD, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115. Tel: 617-732-6682; fax: 617- 232-2869.
    • ,
  • Naomi D.L. Fisher, MD

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
    • ,
  • Marjorie L. McCullough, ScD, RD

      Affiliations

    • Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia, USA

Received 3 September 2008 ,Accepted 12 November 2008.

References 

  1. James GD, Baker PT. Human population biology and hypertension. Evolutionary and ecological aspects of blood pressure. In:  Laragh JH,  Brenner BM editor. Hypertension: pathophysiology, diagnosis, and management. New York, New York: Raven Press, Ltd.; 1995;p. 115–127
  2. Kean BH. The blood pressure of the Kuna Indians. Am J Trop Med Hyg. 1944;24:341–343
  3. Howe J. The Kuna gathering. Contemporary village politics in Panama. Austin, Texas: University of Texas Press; 1986;9–11
  4. Hollenberg NK, Martinez G, McCullough M, Meinking T, Passan D, Preston M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension. 1997;29:171–176
  5. Hollenberg NK, Mohres E, Meinking T, Preston M, Crespo B, Rivera A, et al. Stress and blood pressure in Kuna Amerinds. J Hypertension. 2005;7:714–720
  6. McCullough M, Lin PH. Nutrition, diet, and hypertension. In:  Coulston AM,  Rock CL,  Monsen ER editor. Nutrition in the prevention and treatment of disease. San Diego, California: Academic Press; 2001;p. 303–324
  7. Chevaux KA, Jackson L, Villar ME, Mundt JA, Commisso JF, Adamson GE, et al. Proximate, mineral, and procyanidin content of certain foods and beverages consumed by the Kuna Amerinds of Panama. J Food Comp Anal. 2001;14:553–563
  8. McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, et al. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol Suppl. 2006;47:103–139
  9. Appel L, Moore T, Obarzanek E, Vollmer W, Svetkey L, Sacks F, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117–1124
  10. Fisher NDL, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertension. 2003;21:2281–2286
  11. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr. 2004;23:197–204
  12. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398–405
  13. Taubert D, Berkels R, Roesen R, Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA. 2003;290:1029–1030
  14. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008;138:58–63
  15. Faridi Z, Nijike VY, Dutta S, Ali A, Katz DL. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr. 2008;88:58–63
  16. Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure: a meta analysis. Arch Intern Med. 2007;167:626–634
  17. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu K, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38–50
  18. Buijsse B, Feskens EJ, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med. 2006;166:411–417
  19. Kaplan NM. Treating prehypertension: a review of the evidence. Curr Hypertens Rep. 2008;10:326–329
  20. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr Suppl. 2000;130:2105–2108
  21. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Nat Acad Sci U S A. 2006;103:1024–1029
  22. Hollenberg NK. Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases. J Clin Hypertension Suppl. 2006;4:63–73
  23. Kris-Etherton PM, Keen CL. Evidence that antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipid. 2002;13:14–49
  24. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr Suppl. 2005;81:317–325
  25. Erdman JWJ, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart health: proceedingsof the ILSI North America Flavonoids Workshop. May 31 to June 1, 2005, Washington, DC. J Nutr Suppl 2007;137:718–37.
  26. Keen CL, Holt RR, Oteiza PI, Fraga CG, Schmitz HH. Cocoa antioxidants and cardiovascular health. Am J Clin Nutr Suppl. 2005;81:298–303
  27. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995;155:381–386
  28. Mennen LI, Sapinho D, DeBree A, Arnault N, Bertrais S, Galan P, et al. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr. 2004;134:923–926
  29. Lagiou P, Samoli E, Lagiou A, Tzonou A, Kalandidi A, Peterson J, et al. Intake of specific flavonoid classes and coronary heart disease—a case control study in Greece. Eur J Clin Nutr. 2004;58:1643–1648
  30. Tavani A, Spertini L, Bosetti C, Parpinel M, Gnagnarella P, Bravi F, et al. Intake of specific flavonoids and risk of acute myocardial infarction in Italy. Public Health Nutr. 2006;9:369–374
  31. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996;125:384–389
  32. Lin J, Rexrode KM, Hu F, Albert CM, Chae CU, Rimm EB, et al. Dietary intakes of flavonols and flavones and coronary heart disease in U.S. women. Am J Epidemiol. 2007;165:1305–1313
  33. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong C, Nettleton JA, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895–909
  34. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr. 1997;65:1489–1494
  35. Arts ICW, Hollman PCH, Feskens EJM, Bas Bueno De Mesquita H, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74:227–232
  36. Arts ICW, Jacobs DRJ, Harnack LJ, Gross M, Folsom AR. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology. 2001;12:668–675
  37. Buijsse B, Feskens EJ, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality. Arch Intern Med. 2006;166:411–417
  38. U.S. Department of Agriculture. USDA—Iowa State University database on the isoflavone content of foods. 1999;
  39. U.S. Department of Agriculture. USDA database for the flavonoid content of selected foods. 2003;
  40. U.S. Department of Agriculture. USDA database for the proanthocyanidin content of selected foods. 2004;
  41. Robbins RJ, Kwik-Uribe C, Hammerstone JF, Schmitz HH. Analysis of flavanols in foods: what methods are required to enable meaningful health recommendations?. J Cardiovasc Pharmacol Suppl. 2006;47:110–118
  42. Bayard V, Chamorro F, Motta J, Hollenberg NK. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med. 2007;4:53–58
  43. Sacks F, Obarzanek E, Windhauser M, Svetkey L, Vollmer W, McCullough M, et al. Rationale and design of the dietary approaches to stop hypertension trial (DASH): a multicenter controlled feeding study of dietary patterns to lower blood pressure. Am J Epidemiol. 1995;5:108–118

 This study was supported by Grants from M&M Mars, Inc.

 Conflict of interest: none.

PII: S1933-1711(08)00216-7

doi: 10.1016/j.jash.2008.11.001

Journal of the American Society of Hypertension
Volume 3, Issue 2 , Pages 105-112 , March 2009

Article Tools

* Image Usage & Resolution